Prenatal exposure to maternal depression, neonatal methylation of human glucocorticoid receptor gene (NR3C1) and infant cortisol stress responses

Epigenetics

Volumn 3, Issue 2, 2008, Pages 97-106

  Oberlander, Tim F ^a,b   Weinberg, Joanne ^a,b   Papsdorf, Michael ^a   Grunau, Ruth ^a,b   Misri, Shaila ^a   Devlin, Angela M ^a,b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

(HPA); Hypothalamic pituitary adrenal; Infant stress response; NR3C1 methylation; Prenatal maternal depression

Indexed keywords

BISULFITE; CITALOPRAM; EARLY GROWTH RESPONSE FACTOR 1; FLUOXETINE; FOLIC ACID; GENOMIC DNA; GLUCOCORTICOID RECEPTOR; HYDROCORTISONE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; VENLAFAXINE; VITAMIN; ANTIDEPRESSANT AGENT; NR3C1 PROTEIN, HUMAN;

ADULT; APGAR SCORE; ARTICLE; BINDING SITE; BIRTH WEIGHT; CHILD CARE; CLINICAL ARTICLE; CONTROLLED STUDY; CPG ISLAND; DEPRESSION; DNA METHYLATION; EARLY LIFE STRESS; EXON; FEMALE; HUMAN; HUMAN CELL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INFANT; MALE; MATERNAL BEHAVIOR; MONONUCLEAR CELL; NEWBORN; PERINATAL DRUG EXPOSURE; PRENATAL DRUG EXPOSURE; PRENATAL EXPOSURE; PROMOTER REGION; SECOND TRIMESTER PREGNANCY; THIRD TRIMESTER PREGNANCY; UMBILICAL CORD BLOOD; VITAMIN SUPPLEMENTATION; CYTOLOGY; FETUS BLOOD; GENETICS; HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; METABOLISM; MOLECULAR GENETICS; MOTHER; NUCLEOTIDE SEQUENCE; PREGNANCY; PREGNANCY COMPLICATION; PSYCHOLOGICAL ASPECT;

ANIMALIA;

ADULT; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; BASE SEQUENCE; CPG ISLANDS; DEPRESSION; DNA METHYLATION; EXONS; FEMALE; FETAL BLOOD; HUMANS; HYDROCORTISONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; INFANT; LEUKOCYTES, MONONUCLEAR; MOLECULAR SEQUENCE DATA; MOTHERS; PITUITARY-ADRENAL SYSTEM; PREGNANCY; PREGNANCY COMPLICATIONS; PROMOTER REGIONS (GENETICS); RECEPTORS, GLUCOCORTICOID; SEROTONIN UPTAKE INHIBITORS;

EID: 47149100122     PISSN: 15592294     EISSN: 15592308     Source Type: Journal    
DOI: 10.4161/epi.3.2.6034     Document Type: Article

References (50)

1. Welberg LA, Seckl JR. Prenatal stress, glucocorticoids and the programming of the brain. J Neuroendocrinol 2001; 13:113-28.
2. O'Connor TG, Heron J, Golding J, Glover V. Maternal antenatal anxiety and behavioural/emotional problems in children: a test of a programming hypothesis. J Child Psychol Psychiatry 2003; 44:1025-36.
3. Van Den Hove DL, Steinbusch HW, Scheepens A, Van de Berg WD, Kooiman LA, Boosten BJ, Prickaerts J, Blanco CE. Prenatal stress and neonatal rat brain development. Neuroscience 2006; 137:145-55.
4. Weinstock M. Does prenatal stress impair coping and regulation of hypothalamic-pituitary-adrenal axis? Neurosci Biobehav Rev 1997; 21:1-10.
5. Meaney MJ. Maternal care, gene expression, and the transmission of individual differences in stress reactivity across generations. Annu Rev Neurosci 2001; 24:1161-92.
6. Clarke AS, Wittwer DJ, Abbott DH, Schneider ML. Long-term effects of prenatal stress on HPA axis activity in juvenile rhesus monkeys. Dev Psychobiol 1994; 27:257-69.
7. Liu D, Diorio J, Tannenbaum B, Caldji C, Francis D, Freedman A, Sharma S, Pearson D, Plotsky PM, Meaney MJ. Maternal care, hippocampal glucocorticoid receptors, and hypothalamic-pituitary-adrenal responses to stress. Science 1997; 277:1659-62.
8. Weinstock L, Cohen LS, Bailey JW, Blatman R, Rosenbaum JF. Obstetrical and neonatal outcome following clonazepam use during pregnancy: a case series. Psychother Psychosom 2001; 70:158-62.
9. Van den Bergh BR, Mulder EJ, Mennes M, Glover V. Antenatal maternal anxiety and stress and the neurobehavioural development of the fetus and child: links and possible mechanisms. A review. Neurosci Biobebav Rev 2005; 29:237-58.
10. Wadhwa PD, Sandman CA, Porto M, Dunkel Schetter C, Garite TJ. The association between prenatal stress and infant birth weight and gestational age at birth: a prospective investigation. Am J Obstet Gynecol 1993; 169:858-65.
11. Field T, Diego M, Hernandez Reif M, Vera Y, Gil K, Schanberg S, Kuhn C, Gonzalez Garcia A. Prenatal maternal biochemistry predicts neonatal biochemistry. Int J Neurosci 2004; 114:933-45.
12. Field T, Diego M, Dieter J, Hernandez Reif M, Schanberg S, Kuhn C, Yando R, Bendell D. Prenatal depression effects on the fetus and the newborn. Infant Behavior and Development 2004; 27:216-29.
13. Calhoun KA, Brennan P, Walker EF, Fisher AD, Stowe ZN. Modulation of infant salivary cortisol by maternal depression. Annual Meeting New Research Program and Abstracts. American Psychiatric Association 2001; 122.
14. Weaver IC, Cervoni N, Champagne FA, D'Alessio AC, Sharma S, Seckl JR, Dymov S, Szyf M, Meaney MJ. Epigenetic programming by maternal behavior. Nat Neurosci 2004; 7:847-54.
15. Francis D, Diorio J, Liu D, Meaney MJ. Nongenomic transmission across generations of maternal behavior and stress responses in the rat. Science 1999; 286:1155-8.
16. Mitchell JB, Iny LJ, Meaney MJ. The role of serotonin in the development and environmental regulation of type II corticosteroid receptor binding in rat hippocampus. Brain Res Dev Brain Res 1990; 55:231-5.
17. Laplante P, Diorio J, Meaney MJ. Serotonin regulates hippocampal glucocorticoid receptor expression via a 5-HT7 receptor. Brain Res Dev Brain Res 2002; 139:199-203.
18. McCormick JA, Lyons V, Jacobson MD, Noble J, Diorio J, Nyirenda M, Weaver S, Ester W, Yau JL, Meaney MJ, Seckl JR, Chapman KE. 5′-heterogeneity of glucocorticoid receptor messenger RNA is tissue specific: differential regulation of variant transcripts by early-life events. Mol Endocrinol 2000; 14:506-17.
19. Fleming AS, O'Day DH, Kraemer GW. Neurobiology of mother-infant interactions: experience and central nervous system plasticity across development and generations. Neurosci Biobehav Rev 1999; 23:673-85.
20. Meaney MJ, Szyf M. Maternal care as a for experience-dependent chromatin plasticity? Trends Neurosci 2005; 28:456-63.
21. Weaver IC, D'Alessio AC, Brown SE, Hellstrom IC, Dymov S, Sharma S, Szyf M, Meaney MJ. The transcription factor nerve growth factor-inducible protein a mediates epigenetic programming: altering epigenetic marks by immediate-early genes. J Neurosci 2007; 27:1756-68.
22. Weaver IC, La PP, Weaver S, Parent A, Sharma S, Diorio J, Chapman KE, Seckl JR, Szyf M, Meaney MJ. Early enviromnental regulation of hippocampal glucocorticoid receptor gene expression: characterization of intracellular mediators and potential genomic target sites. Mol Cell Endocrinol 2001; 185:205-18.
23. Breslin MB, Geng CD, Vedeckis WV. Multiple promoters exist in the human GR gene, one of which is activated by glucocorticoids. Mol Endocrinol 2001; 15:1381-95.
24. Presul E, Schmidt S, Kofler R, Helmberg A. Identification, tissue expression, and glucocorticoid responsiveness of alternative first exons of the human glucocorticoid receptor. J Mol Endocrinol 2007; 38:79-90.
25. Turner JD, Schote AR, Macedo JA, Pelascini LP, Muller CP. Tissue specific glucocorticoid receptor expression, a role for alternative first exon usage? Biochem Pharmacol 2006; 72:1529-37.
26. Moser D, Molitor A, Kumsta R, Tatschner T, Riederer P, Meyer J. The glucocorticoid receptor gene exon 1-F promoter is not methylated at the NGF1-A binding site in the human hippocampus. The World Journal of Biological Psychiatry 2007; 8:262-8.
27. Gillespie CF, Nemeroff CB. Hypercortisolemia and depression. Psychosom Med 2005; 67:26-8.
28. Oberlander TF, Warburton W, Misri S, Aghajanian J, Hertzman C. Neonatal outcomes after prenatal exposure to selective serotonin reuptake inhibitor antidepressants and maternal depression using population-based linked health data. Arch Gen Psychiatry 2006; 63:898-906.
29. Yau JL, Hibberd C, Noble J, Seckl JR. The effect of chronic fluoxetine treatment on brain corticosteroid receptor mRNA expression and spatial memory in young and aged rats. Brain Res Mol Brain Res 2002; 106:117-23.
30. Bjartmar L, Johansson IM, Marcusson J, Ross SB, Seckl JR, Olsson T. Selective effects on NGFI-A, MR, GR and NGFI-B hippocampal mRNA expression after chronic treatment with different subclasses of antidepressants in the rat. Psychopharmacology (Berl) 2000; 151:7-12.
31. Oberlander TF, Weinberg J, Mayes L, Riggs W, Rurak D, Papsdorf M, Misri S, Grunau R. Hypothalamic-pituitary-adrenal (HPA) axis function in 3 month old infants with prenatal serotonin reuptake inhibitor (SRI) antidepressant exposure. Abstract. XVIth Biennial International Conference on Infant Studies. Vancouver, BC 2008.
32. Mayes LC, Bornstein MH, Chawarska K, Granger RH. Information processing and developmental assessments in 3-month-old infants exposed prenatally to cocaine. Pediatrics 1995; 95:539-45.
33. Prechtl HF, O'Brien MJ. Behavioural states of the full-term newborn: the emergence of a concept. In: Stratton P, editor. Psychobiology of the Human Newborn. New York, NY: John Wiley and Sons Ltd 1982; 53-73.
34. Yang AS, Estecio MR, Doshi K, Kondo Y, Tajara EH, Issa JP. A simple method for estimating global DNA methylation using bisulfite PCR of repetitive DNA elements. Nucleic Acids Res 2004; 32:38.
35. Turner JD, Muller CP. Structure of the glucocorticoid receptor (NR3C1) gene 5′ untranslated region: identification, and tissue distribution of multiple new human exon 1. J Mol Endocrinol 2005; 35:283-92.
36. Dupont JM, Tost J, Jammes H, Gut IG. De novo quantitative bisulfite sequencing using the pyrosequencing technology. Anal Biochem 2004; 333:119-27.
37. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23:56-62.
38. Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol 1959; 32:50-5.
39. Cox JL, Holden JM, Sagovsky R. Detection of postnatal depression. Development of the 10-item Edinburgh Postnatal Depression Scale. Br J Psychiatry 1987; 150:782-6.
40. Abidin RR. Parenting Stress Index. Charlottesville, VA: Pediatric Psychology Press; 1990.
41. Perneger TV. What's wrong with Bonferroni adjustments. BMJ 1998; 316:1236-8.
42. Oberlander TF, Misri S, Fitzgerald CE, Kostaras X, Rurak D, Riggs W. Pharmacologic factors associated with transient neonatal symptoms following prenatal psychotropic medication exposure. J Clin Psychiatry 2004; 65:230-7.
43. Kim J, Riggs KW, Misri S, Kent N, Oberlander TF, Grunau RE, Fitzgerald C, Rurak DW. Stereoselective disposition of fluoxetine and norfluoxetine during pregnancy and breastfeeding. Br J Clin Pharmacol 2006; 61:155-63.
44. Moses Kolko EL, Bogen D, Perel J, Bregar A, Uhl K, Levin B, Wisner KL. Neonatal signs after late in utero exposure to serotonin reuptake inhibitors: literature review and implications for clinical applications. JAMA 2005; 293:2372-83.
45. Oberlander TF, Bonaguro RJ, Misri S, Papsdorf M, Ross CJ, Simpson EM. Infant serotonin transporter (SLC6A4) promoter genotype is associated with adverse neonatal outcomes after prenatal exposure to serotonin reuptake inhibitor medications. Mol Psychiatry 2008; 13:65-73.
46. Oberlander TF, Reebye P, Misri S, Papsdorf M, Kim J, Grunau R. Externalizing and attentional behaviors in children of depressed mothers treated with a selective serotonin reuptake inhibitor antidepressant during pregnancy. Arch Pediatr Adolesc Med 2007; 161:22-9.
47. Yau JL, Noble J, Chapman KE, Seckl JR. Differential regulation of variant glucocorticoid receptor mRNAs in the rat hippocampus by the antidepressant fluoxetine. Brain Res Mol Brain Res 2004; 129:189-92.
48. Cartharius K, Frech K, Grote K, Klocke B, Haltmeier M, Klingenhoff A, Frisch M, Bayerlein M, Werner T. MatInspector and beyond: promoter analysis based on transcription factor binding sites. Bioinformatics 2005; 21:2933-42.
49. Davis CD, Uthus EO. DNA Methylation, Cancer Susceptibility, and Nutrient Interactions. Experimental Biology and Medicine 2004; 229:988-95.
50. van Engeland M, Weijenberg MP, Roemen GM, Brink M, de Bruine AP, Goldbohm RA, van den Brandt PA, Baylin SB, de Goeij AF, Herman JG. Effects of dietary folate and alcohol intake on promoter methylation in sporadic colorectal cancer: the Netherlands cohort study on diet and cancer. Cancer Res 2003; 63:3133-7.